1. Committee for Proprietary Medicinal Products 2000
2. The history and conduct of safety assessment of marketed medicines studies in the UK;Palmer;Int J Pharm Med,1998
3. Pharmacovigilance: paradise lost, regained or postponed?;Rawlins;J Roy Coll Physicians London,1995
4. Review of company postmarketing surveillance studies;Waller;Br Med J,1992
5. Guidelines for company sponsored safety assessment of marketed medicines;Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association;Br J Clin Pharmacol,1994